Skip to main content
. 2015 Apr 10;9:125. doi: 10.3389/fncel.2015.00125

Table 2.

Mean ΔG of binding during the MD trajectory and experimental SV2A binding data (see text for references).

Ligand ΔG (kcal/mol, Mean ± SD) Experimental SV2A pKd
Levetiracetam -5.60 ± 0.24 6.1
Brivaracetam -6.50 ± 0.31 7.2
Seletracetam -6.08 ± 0.41 7.1
UCB30889 -8.46 ± 0.32 7.6